A three-dimensional in vitro model of angiogenesis in the airway mucosa

H. Garrett Thompson, David T. Truong, Craig K. Griffith, Steven George

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Bronchial asthma is an inflammatory disease characterized by chronic intermittent bronchoconstriction. A key feature of the disease is structural changes in the airway wall (airway remodeling) consistent with tissue growth and chronic wound healing including angiogenesis. The epithelium directs mesenchymal processes during both embryogenesis and wound healing, and thus we hypothesized that the bronchial epithelium plays a critical role in directing angiogenesis. To study angiogenesis in the airways, we have developed a three-dimensional (3-D) in vitro model of the airway mucosa that consists of normal differentiated human bronchial epithelial cells (NHBE), normal human lung fibroblasts (NHLF), and human umbilical vein endothelial cells (HUVEC). The HUVEC are coated on dextran beads and suspended in a fibrin gel approximately 2 mm beneath a confluent monolayer of NHLF which are just beneath the confluent monolayer of differentiated NHBE. In the presence of fibroblasts, visible capillaries reaching lengths of up to 1 mm sprout from the HUVEC-coated beads. Over 11 days in culture, the bronchial epithelium produces transforming growth factor-β2 (TGFβ2, 60 pg/ml), significantly increases vascular endothelial growth factor (VEGF) more than 6-fold to a concentration of 1.85 ng/ml, but does not significantly impact total network formation. Exogenous TGFβ2 stimulates VEGF production in a dose-dependent fashion (0-400 pg/ml) through a MAPK-dependent pathway, but also inhibits capillary network formation. We conclude that the bronchial epithelium produces biologically relevant concentrations of VEGF and TGFβ2 in a 3-D model of the airway mucosa that may be useful in probing mechanisms of angiogenesis in asthma.

Original languageEnglish (US)
Pages (from-to)141-148
Number of pages8
JournalPulmonary Pharmacology and Therapeutics
Volume20
Issue number2
DOIs
StatePublished - Apr 1 2007

Fingerprint

Human Umbilical Vein Endothelial Cells
Mucous Membrane
Epithelium
Vascular Endothelial Growth Factor A
Endothelial cells
Fibroblasts
Wound Healing
Asthma
Epithelial Cells
Monolayers
Airway Remodeling
Lung
Bronchoconstriction
Transforming Growth Factors
Dextrans
Fibrin
Embryonic Development
Chronic Disease
Cell culture
Gels

Keywords

  • 3-dimensional
  • Airway mucosa
  • Angiogenesis
  • Asthma
  • Epithelium
  • Fibrin gel
  • In vitro model
  • TGFbeta
  • U0126
  • VEGF

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Biochemistry, medical
  • Pharmacology (medical)

Cite this

A three-dimensional in vitro model of angiogenesis in the airway mucosa. / Thompson, H. Garrett; Truong, David T.; Griffith, Craig K.; George, Steven.

In: Pulmonary Pharmacology and Therapeutics, Vol. 20, No. 2, 01.04.2007, p. 141-148.

Research output: Contribution to journalArticle

Thompson, H. Garrett ; Truong, David T. ; Griffith, Craig K. ; George, Steven. / A three-dimensional in vitro model of angiogenesis in the airway mucosa. In: Pulmonary Pharmacology and Therapeutics. 2007 ; Vol. 20, No. 2. pp. 141-148.
@article{eb3897344f764af5a6ecf0c973eda647,
title = "A three-dimensional in vitro model of angiogenesis in the airway mucosa",
abstract = "Bronchial asthma is an inflammatory disease characterized by chronic intermittent bronchoconstriction. A key feature of the disease is structural changes in the airway wall (airway remodeling) consistent with tissue growth and chronic wound healing including angiogenesis. The epithelium directs mesenchymal processes during both embryogenesis and wound healing, and thus we hypothesized that the bronchial epithelium plays a critical role in directing angiogenesis. To study angiogenesis in the airways, we have developed a three-dimensional (3-D) in vitro model of the airway mucosa that consists of normal differentiated human bronchial epithelial cells (NHBE), normal human lung fibroblasts (NHLF), and human umbilical vein endothelial cells (HUVEC). The HUVEC are coated on dextran beads and suspended in a fibrin gel approximately 2 mm beneath a confluent monolayer of NHLF which are just beneath the confluent monolayer of differentiated NHBE. In the presence of fibroblasts, visible capillaries reaching lengths of up to 1 mm sprout from the HUVEC-coated beads. Over 11 days in culture, the bronchial epithelium produces transforming growth factor-β2 (TGFβ2, 60 pg/ml), significantly increases vascular endothelial growth factor (VEGF) more than 6-fold to a concentration of 1.85 ng/ml, but does not significantly impact total network formation. Exogenous TGFβ2 stimulates VEGF production in a dose-dependent fashion (0-400 pg/ml) through a MAPK-dependent pathway, but also inhibits capillary network formation. We conclude that the bronchial epithelium produces biologically relevant concentrations of VEGF and TGFβ2 in a 3-D model of the airway mucosa that may be useful in probing mechanisms of angiogenesis in asthma.",
keywords = "3-dimensional, Airway mucosa, Angiogenesis, Asthma, Epithelium, Fibrin gel, In vitro model, TGFbeta, U0126, VEGF",
author = "Thompson, {H. Garrett} and Truong, {David T.} and Griffith, {Craig K.} and Steven George",
year = "2007",
month = "4",
day = "1",
doi = "10.1016/j.pupt.2005.12.001",
language = "English (US)",
volume = "20",
pages = "141--148",
journal = "Pulmonary Pharmacology and Therapeutics",
issn = "1094-5539",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - A three-dimensional in vitro model of angiogenesis in the airway mucosa

AU - Thompson, H. Garrett

AU - Truong, David T.

AU - Griffith, Craig K.

AU - George, Steven

PY - 2007/4/1

Y1 - 2007/4/1

N2 - Bronchial asthma is an inflammatory disease characterized by chronic intermittent bronchoconstriction. A key feature of the disease is structural changes in the airway wall (airway remodeling) consistent with tissue growth and chronic wound healing including angiogenesis. The epithelium directs mesenchymal processes during both embryogenesis and wound healing, and thus we hypothesized that the bronchial epithelium plays a critical role in directing angiogenesis. To study angiogenesis in the airways, we have developed a three-dimensional (3-D) in vitro model of the airway mucosa that consists of normal differentiated human bronchial epithelial cells (NHBE), normal human lung fibroblasts (NHLF), and human umbilical vein endothelial cells (HUVEC). The HUVEC are coated on dextran beads and suspended in a fibrin gel approximately 2 mm beneath a confluent monolayer of NHLF which are just beneath the confluent monolayer of differentiated NHBE. In the presence of fibroblasts, visible capillaries reaching lengths of up to 1 mm sprout from the HUVEC-coated beads. Over 11 days in culture, the bronchial epithelium produces transforming growth factor-β2 (TGFβ2, 60 pg/ml), significantly increases vascular endothelial growth factor (VEGF) more than 6-fold to a concentration of 1.85 ng/ml, but does not significantly impact total network formation. Exogenous TGFβ2 stimulates VEGF production in a dose-dependent fashion (0-400 pg/ml) through a MAPK-dependent pathway, but also inhibits capillary network formation. We conclude that the bronchial epithelium produces biologically relevant concentrations of VEGF and TGFβ2 in a 3-D model of the airway mucosa that may be useful in probing mechanisms of angiogenesis in asthma.

AB - Bronchial asthma is an inflammatory disease characterized by chronic intermittent bronchoconstriction. A key feature of the disease is structural changes in the airway wall (airway remodeling) consistent with tissue growth and chronic wound healing including angiogenesis. The epithelium directs mesenchymal processes during both embryogenesis and wound healing, and thus we hypothesized that the bronchial epithelium plays a critical role in directing angiogenesis. To study angiogenesis in the airways, we have developed a three-dimensional (3-D) in vitro model of the airway mucosa that consists of normal differentiated human bronchial epithelial cells (NHBE), normal human lung fibroblasts (NHLF), and human umbilical vein endothelial cells (HUVEC). The HUVEC are coated on dextran beads and suspended in a fibrin gel approximately 2 mm beneath a confluent monolayer of NHLF which are just beneath the confluent monolayer of differentiated NHBE. In the presence of fibroblasts, visible capillaries reaching lengths of up to 1 mm sprout from the HUVEC-coated beads. Over 11 days in culture, the bronchial epithelium produces transforming growth factor-β2 (TGFβ2, 60 pg/ml), significantly increases vascular endothelial growth factor (VEGF) more than 6-fold to a concentration of 1.85 ng/ml, but does not significantly impact total network formation. Exogenous TGFβ2 stimulates VEGF production in a dose-dependent fashion (0-400 pg/ml) through a MAPK-dependent pathway, but also inhibits capillary network formation. We conclude that the bronchial epithelium produces biologically relevant concentrations of VEGF and TGFβ2 in a 3-D model of the airway mucosa that may be useful in probing mechanisms of angiogenesis in asthma.

KW - 3-dimensional

KW - Airway mucosa

KW - Angiogenesis

KW - Asthma

KW - Epithelium

KW - Fibrin gel

KW - In vitro model

KW - TGFbeta

KW - U0126

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=33751159859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751159859&partnerID=8YFLogxK

U2 - 10.1016/j.pupt.2005.12.001

DO - 10.1016/j.pupt.2005.12.001

M3 - Article

C2 - 16414296

AN - SCOPUS:33751159859

VL - 20

SP - 141

EP - 148

JO - Pulmonary Pharmacology and Therapeutics

JF - Pulmonary Pharmacology and Therapeutics

SN - 1094-5539

IS - 2

ER -